Table 2.
Patient characteristics. SD: standard deviation; PZ: peripheral zone; TZ: transition zone; pl: posterolateral; pm: posteromedial, a: anterior; PI-RADS: Prostate imaging-reporting and data system; PSA: prostate-specific antigen.
| Parameter | Variable | Value |
|---|---|---|
| Age (years) | Mean ± SD | 64.4 ± 6.2 |
| Number of lesions | 1 | 12 (52%) |
| 2 | 8 (39%) | |
| 3 | 2 (9%) | |
| Lesion location | PZpl | 8 (35%) |
| PZpm | 4 (17%) | |
| PZa | 6 (26%) | |
| TZa | 5 (22%) | |
| PIRADS score | 3 | 3 (13%) |
| 4 | 14 (61%) | |
| 5 | 6 (26%) | |
| Gleason score | 6 | 1 (4%) |
| 7a | 11 (48%) | |
| 7b | 9 (39%) | |
| 9 | 2 (9%) | |
| Tumor size | pT2a | 1 (4%) |
| pT2c | 13 (57%) | |
| pT3a | 4 (17%) | |
| pT3b | 5 (22%) | |
| Nodal status | pN0 | 22 (96%) |
| pN1 | 1 (4%) | |
| Metastasis | cM0 | 23 (100%) |
| PSA (ng/mL) | Mean ± SD | 14.4 ± 18.4 |